Replies to post #237987 on Biotech Values

[DewDiligence]

Right. The 1.0-log reduction was in HBV RNA relative to baseline.

The reduction in HBV DNA relative to baseline is not a meaningful number in nuke-suppressed patients, who have undetectable HBV DNA (or an extremely low detectable level) while continuing nuke treatment.